Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Restructuring Charges

2.8 / 5 stars · 68/120 Roast Me

BRISTOL-MYERS SQUIBB COMPANY Restructuring Charges

BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Restructuring Charges of $56.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RestructuringCharges · last filed 2026-07-30

  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for the quarter ending 2026-06-30 was $56.00M, a 74.89% decline year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for the quarter ending 2026-03-31 was $5.00M, a 96.24% decline year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for the quarter ending 2025-12-31 was $131.00M, a 70.13% increase year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for the quarter ending 2025-09-30 was $75.00M, a 3.85% decline year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for fiscal 2025 was $563.00M, a 11.34% decline from fiscal 2024.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for fiscal 2024 was $635.00M, a 73.97% increase from fiscal 2023.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for fiscal 2023 was $365.00M, a 386.67% increase from fiscal 2022.
  • BRISTOL-MYERS SQUIBB COMPANY restructuring charges for fiscal 2022 was $75.00M, a 55.62% decline from fiscal 2021.
Period endRestructuring Charges 3 monthRestructuring Charges 3 month as first filedRestructuring Charges 6 monthRestructuring Charges 6 month as first filedRestructuring Charges 9 monthRestructuring Charges 9 month as first filedRestructuring Charges 12 month
2026-06-30$56.00M
10-Q · filed 2026-07-30
$61.00M
10-Q · filed 2026-07-30
$192.00M
derived: sum of 3 quarters · filed 2026-07-30
$267.00M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$5.00M
10-Q · filed 2026-04-30
$136.00M
derived: sum of 2 quarters · filed 2026-04-30
$211.00M
derived: sum of 3 quarters · filed 2026-04-30
$434.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$131.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$206.00M
derived: sum of 2 quarters · filed 2026-02-11
$429.00M
derived: sum of 3 quarters · filed 2026-07-30
$563.00M
10-K · filed 2026-02-11
2025-09-30$75.00M
10-Q · filed 2025-10-30
$298.00M
derived: sum of 2 quarters · filed 2026-07-30
$432.00M
10-Q · filed 2025-10-30
$508.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$223.00M
10-Q · filed 2026-07-30
$356.00M
10-Q · filed 2026-07-30
$433.00M
derived: sum of 3 quarters · filed 2026-07-30
$511.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$133.00M
10-Q · filed 2026-04-30
$210.00M
derived: sum of 2 quarters · filed 2026-04-30
$288.00M
derived: sum of 3 quarters · filed 2026-04-30
$548.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$77.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$155.00M
derived: sum of 2 quarters · filed 2026-02-11
$415.00M
derived: sum of 3 quarters · filed 2026-02-11
$635.00M
10-K · filed 2026-02-11
2024-09-30$78.00M
10-Q · filed 2025-10-30
$338.00M
derived: sum of 2 quarters · filed 2025-10-30
$558.00M
10-Q · filed 2025-10-30
$602.00M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$260.00M
10-Q · filed 2025-07-31
$480.00M
10-Q · filed 2025-07-31
$524.00M
derived: sum of 3 quarters · filed 2026-02-11
$665.00M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$220.00M
10-Q · filed 2025-04-24
$264.00M
derived: sum of 2 quarters · filed 2026-02-11
$405.00M
derived: sum of 3 quarters · filed 2026-02-11
$518.00M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$44.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$185.00M
derived: sum of 2 quarters · filed 2026-02-11
$298.00M
derived: sum of 3 quarters · filed 2026-02-11
$365.00M
10-K · filed 2026-02-11
2023-09-30$141.00M
10-Q · filed 2024-10-31
$254.00M
derived: sum of 2 quarters · filed 2024-10-31
$321.00M
10-Q · filed 2024-10-31
$336.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$113.00M
10-Q · filed 2024-07-26
$180.00M
10-Q · filed 2024-07-26
$195.00M
derived: sum of 3 quarters · filed 2025-02-12
$212.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$67.00M
10-Q · filed 2024-04-25
$82.00M
derived: sum of 2 quarters · filed 2025-02-12
$99.00M
derived: sum of 3 quarters · filed 2025-02-12
$119.00M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$32.00M
derived: sum of 2 quarters · filed 2025-02-12
$52.00M
derived: sum of 3 quarters · filed 2025-02-12
$75.00M
10-K · filed 2025-02-12
2022-09-30$17.00M
10-Q · filed 2023-10-26
$37.00M
derived: sum of 2 quarters · filed 2023-10-26
$60.00M
10-Q · filed 2023-10-26
$79.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30$20.00M
10-Q · filed 2023-07-27
$43.00M
10-Q · filed 2023-07-27
$62.00M
derived: sum of 3 quarters · filed 2024-02-13
$89.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31$23.00M
10-Q · filed 2023-04-27
$42.00M
derived: sum of 2 quarters · filed 2024-02-13
$69.00M
derived: sum of 3 quarters · filed 2024-02-13
$147.00M
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31$19.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
$46.00M
derived: sum of 2 quarters · filed 2024-02-13
$124.00M
derived: sum of 3 quarters · filed 2024-02-13
$169.00M
10-K · filed 2024-02-13
2021-09-30$27.00M
10-Q · filed 2022-10-26
$105.00M
derived: sum of 2 quarters · filed 2022-10-26
$150.00M
10-Q · filed 2022-10-26
$229.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30$78.00M
10-Q · filed 2022-07-27
$123.00M
10-Q · filed 2022-07-27
$202.00M
derived: sum of 3 quarters · filed 2023-02-14
$378.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31$45.00M
10-Q · filed 2022-04-29
$124.00M
derived: sum of 2 quarters · filed 2023-02-14
$300.00M
derived: sum of 3 quarters · filed 2023-02-14
$415.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31$79.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$255.00M
derived: sum of 2 quarters · filed 2023-02-14
$370.00M
derived: sum of 3 quarters · filed 2023-02-14
$530.00M
10-K · filed 2023-02-14
2020-09-30$176.00M
10-Q · filed 2021-10-27
$291.00M
derived: sum of 2 quarters · filed 2021-10-27
$451.00M
10-Q · filed 2021-10-27
$720.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-06-30$115.00M
10-Q · filed 2021-07-28
$275.00M
10-Q · filed 2021-07-28
$544.00M
derived: sum of 3 quarters · filed 2022-02-09
$554.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-03-31$160.00M
10-Q · filed 2021-04-29
$429.00M
derived: sum of 2 quarters · filed 2022-02-09
$439.00M
derived: sum of 3 quarters · filed 2022-02-09
$449.00M
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$269.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$279.00M
derived: sum of 2 quarters · filed 2022-02-09
$289.00M
derived: sum of 3 quarters · filed 2022-02-09
$301.00M
10-K · filed 2022-02-09
2019-09-30$10.00M
10-Q · filed 2020-11-05
$20.00M
derived: sum of 2 quarters · filed 2020-11-05
$32.00M
10-Q · filed 2020-11-05
$61.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30$10.00M
10-Q · filed 2020-08-06
$22.00M
10-Q · filed 2020-08-06
$51.00M
derived: sum of 3 quarters · filed 2021-02-10
$96.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31$12.00M
10-Q · filed 2020-05-07
$41.00M
derived: sum of 2 quarters · filed 2021-02-10
$86.00M
derived: sum of 3 quarters · filed 2021-02-10
$123.00M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31$29.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
$74.00M
derived: sum of 2 quarters · filed 2021-02-10
$111.00M
derived: sum of 3 quarters · filed 2021-02-10
$131.00M
10-K · filed 2021-02-10
2018-09-30$45.00M
10-Q · filed 2019-10-31
$82.00M
derived: sum of 2 quarters · filed 2019-10-31
$102.00M
10-Q · filed 2019-10-31
$188.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30$37.00M
10-Q · filed 2019-07-25
$57.00M
10-Q · filed 2019-07-25
$143.00M
derived: sum of 3 quarters · filed 2020-02-24
$171.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31$20.00M
10-Q · filed 2019-04-25
$106.00M
derived: sum of 2 quarters · filed 2020-02-24
$134.00M
derived: sum of 3 quarters · filed 2020-02-24
$149.00M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$86.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$114.00M
derived: sum of 2 quarters · filed 2020-02-24
$129.00M
derived: sum of 3 quarters · filed 2020-02-24
$293.00M
10-K · filed 2020-02-24
2017-09-30$28.00M
10-Q · filed 2018-10-25
$43.00M
derived: sum of 2 quarters · filed 2018-10-25
$207.00M
10-Q · filed 2018-10-25
$275.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30$15.00M
10-Q · filed 2018-07-26
$179.00M
10-Q · filed 2018-07-26
$247.00M
derived: sum of 3 quarters · filed 2019-02-25
$266.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31$164.00M
10-Q · filed 2018-04-26
$232.00M
derived: sum of 2 quarters · filed 2019-02-25
$251.00M
derived: sum of 3 quarters · filed 2019-02-25
$269.00M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31$68.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
$87.00M
derived: sum of 2 quarters · filed 2019-02-25
$105.00M
derived: sum of 3 quarters · filed 2019-02-25
$109.00M
10-K · filed 2019-02-25
2016-09-30$19.00M
10-Q · filed 2017-10-26
$37.00M
derived: sum of 2 quarters · filed 2017-10-26
$41.00M
10-Q · filed 2017-10-26
$109.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-30$18.00M
10-Q · filed 2017-07-27
$22.00M
10-Q · filed 2017-07-27
$90.00M
derived: sum of 3 quarters · filed 2018-02-13
$100.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-31$4.00M
10-Q · filed 2017-04-27
$72.00M
derived: sum of 2 quarters · filed 2018-02-13
$82.00M
derived: sum of 3 quarters · filed 2018-02-13
$110.00M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-31$68.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$78.00M
derived: sum of 2 quarters · filed 2018-02-13
$106.00M
derived: sum of 3 quarters · filed 2018-02-13
$118.00M
10-K · filed 2018-02-13
2015-09-30$10.00M
10-Q · filed 2016-10-27
$38.00M
derived: sum of 2 quarters · filed 2016-10-27
$50.00M
10-Q · filed 2016-10-27
$141.00M
derived: sum of 4 quarters · filed 2017-02-21
2015-06-30$28.00M
10-Q · filed 2016-07-28
$40.00M
10-Q · filed 2016-07-28
$131.00M
derived: sum of 3 quarters · filed 2017-02-21
$166.00M
derived: sum of 4 quarters · filed 2017-02-21
2015-03-31$12.00M
10-Q · filed 2016-04-28
$103.00M
derived: sum of 2 quarters · filed 2017-02-21
$138.00M
derived: sum of 3 quarters · filed 2017-02-21
$154.00M
derived: sum of 4 quarters · filed 2017-02-21
2014-12-31$91.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
$126.00M
derived: sum of 2 quarters · filed 2017-02-21
$142.00M
derived: sum of 3 quarters · filed 2017-02-21
$163.00M
10-K · filed 2017-02-21
2014-09-30$35.00M
10-Q · filed 2015-10-27
$51.00M
derived: sum of 2 quarters · filed 2015-10-27
$72.00M
10-Q · filed 2015-10-27
$86.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-30$16.00M
10-Q · filed 2015-07-23
$37.00M
10-Q · filed 2015-07-23
$51.00M
derived: sum of 3 quarters · filed 2016-02-12
$57.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-31$21.00M
10-Q · filed 2015-04-28
$35.00M
derived: sum of 2 quarters · filed 2016-02-12
$41.00M
derived: sum of 3 quarters · filed 2016-02-12
$214.00M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-31$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$20.00M
derived: sum of 2 quarters · filed 2016-02-12
$193.00M
derived: sum of 3 quarters · filed 2016-02-12
$226.00M
10-K · filed 2016-02-12
2013-09-30$6.00M
10-Q · filed 2014-10-24
$179.00M
derived: sum of 2 quarters · filed 2014-10-24
$212.00M
10-Q · filed 2014-10-24
$315.00M
derived: sum of 4 quarters · filed 2015-02-13
2013-06-30$173.00M
10-Q · filed 2014-07-24
$206.00M
10-Q · filed 2014-07-24
$309.00M
derived: sum of 3 quarters · filed 2015-02-13
$338.00M
derived: sum of 4 quarters · filed 2015-02-13
2013-03-31$33.00M
10-Q · filed 2014-04-29
$136.00M
derived: sum of 2 quarters · filed 2015-02-13
$165.00M
derived: sum of 3 quarters · filed 2015-02-13
$185.00M
derived: sum of 4 quarters · filed 2015-02-13
2012-12-31$103.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13
$132.00M
derived: sum of 2 quarters · filed 2015-02-13
$152.00M
derived: sum of 3 quarters · filed 2015-02-13
$174.00M
10-K · filed 2015-02-13
2012-09-30$29.00M
10-Q · filed 2013-10-23
$49.00M
derived: sum of 2 quarters · filed 2013-10-23
$71.00M
10-Q · filed 2013-10-23
$95.00M
derived: sum of 4 quarters · filed 2013-10-23
2012-06-30$20.00M
10-Q · filed 2013-07-25
$42.00M
10-Q · filed 2013-07-25
$66.00M
derived: sum of 3 quarters · filed 2013-07-25
$74.00M
derived: sum of 4 quarters · filed 2013-07-25
2012-03-31$22.00M
10-Q · filed 2013-04-25
$46.00M
derived: sum of 2 quarters · filed 2013-04-25
$54.00M
derived: sum of 3 quarters · filed 2013-04-25
$94.00M
derived: sum of 4 quarters · filed 2013-04-25
2011-12-31$24.00M
10-K · filed 2012-02-17
$32.00M
derived: sum of 2 quarters · filed 2012-10-24
$72.00M
derived: sum of 3 quarters · filed 2012-10-24
$116.00M
10-K · filed 2014-02-14
2011-09-30$8.00M
10-Q · filed 2012-10-24
$48.00M
derived: sum of 2 quarters · filed 2012-10-24
$92.00M
10-Q · filed 2012-10-24
$155.00M
derived: sum of 4 quarters · filed 2012-10-24
2011-06-30$40.00M
10-Q · filed 2012-07-25
$84.00M
10-Q · filed 2012-07-25
$147.00M
derived: sum of 3 quarters · filed 2012-07-25
$162.00M
derived: sum of 4 quarters · filed 2012-07-25
2011-03-31$44.00M
10-Q · filed 2012-04-26
$107.00M
derived: sum of 2 quarters · filed 2012-04-26
$122.00M
derived: sum of 3 quarters · filed 2012-04-26
$146.00M
derived: sum of 4 quarters · filed 2012-04-26
2010-12-31$63.00M
10-K · filed 2012-02-17
$78.00M
derived: sum of 2 quarters · filed 2012-02-17
$102.00M
derived: sum of 3 quarters · filed 2012-02-17
$113.00M
10-K · filed 2013-02-15
2010-09-30$15.00M
10-K · filed 2012-02-17
$63.00M
10-Q · filed 2010-10-26
$39.00M
derived: sum of 2 quarters · filed 2012-02-17
$50.00M
10-Q · filed 2011-10-27
$395.00M
10-Q · filed 2010-10-26
-$1.00M
derived: sum of 4 quarters · filed 2012-02-17
2010-06-30$24.00M
10-K · filed 2012-02-17
$35.00M
10-Q · filed 2011-07-28
-$16.00M
derived: sum of 3 quarters · filed 2012-02-17
$68.00M
derived: sum of 4 quarters · filed 2012-02-17
2010-03-31$11.00M
10-K · filed 2012-02-17
-$40.00M
derived: sum of 2 quarters · filed 2012-02-17
$44.00M
derived: sum of 3 quarters · filed 2012-02-17
$63.00M
derived: sum of 4 quarters · filed 2012-02-17
2009-12-31-$51.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
$33.00M
derived: sum of 2 quarters · filed 2012-02-17
$52.00M
derived: sum of 3 quarters · filed 2012-02-17
$136.00M
10-K · filed 2012-02-17
2009-09-30$84.00M
10-Q · filed 2010-10-26
$54.00M
10-Q · filed 2009-10-22
$103.00M
derived: sum of 2 quarters · filed 2010-10-26
$187.00M
10-Q · filed 2010-10-26
$101.00M
10-Q · filed 2009-10-22
$270.00M
derived: sum of 4 quarters · filed 2011-02-18
2009-06-30$19.00M
10-Q · filed 2010-07-22
$20.00M
10-Q · filed 2009-07-23
$38.00M
10-Q · filed 2010-07-22
$47.00M
10-Q · filed 2009-07-23
$186.00M
derived: sum of 3 quarters · filed 2011-02-18
$212.00M
derived: sum of 4 quarters · filed 2011-02-18
2009-03-31$19.00M
10-Q · filed 2010-04-29
$167.00M
derived: sum of 2 quarters · filed 2011-02-18
$193.00M
derived: sum of 3 quarters · filed 2011-02-18
$223.00M
derived: sum of 4 quarters · filed 2011-02-18
2008-12-31$148.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18
$174.00M
derived: sum of 2 quarters · filed 2011-02-18
$204.00M
derived: sum of 3 quarters · filed 2011-02-18
$215.00M
10-K · filed 2011-02-18
2008-09-30$26.00M
10-Q · filed 2009-10-22
$56.00M
derived: sum of 2 quarters · filed 2009-10-22
$67.00M
10-Q · filed 2009-10-22
2008-06-30$30.00M
10-Q · filed 2009-07-23
$41.00M
10-Q · filed 2009-07-23
2007-12-31$180.00M
10-K · filed 2010-02-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64